Herein, our findings established a novel YY1‐assisted DDX3X‐KTN1 regulatory axis, which would shed some light on the signaling involved in cell invasion and progression in breast cancer and open an avenue in finding novel therapeutic targets for breast cancer. This evidence concerns the gene KTN1 and breast carcinoma.